Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Tural, C; Sola, R; Alvarez, NP; Molto, J; Sanchez, M; Zamora, AM; Ornelas, A; Laguno, M; Gonzalez, J; von Wichmann, MA; Tellez, MJ; Paredes, R; Clotet, B.

Effect of an induction period of pegylated interferon-alpha 2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

ANTIVIRAL THERAPY. 2011; 16(6): 833-841 Nº de citas: 1 [doi:10.3851/IMP1837]

Parra, J; Portilla, J; Pulido, F; Sanchez-de la Rosa, R; Alonso-Villaverde, C; Berenguer, J; Blanco, JL; Domingo, P; Dronda, F; Galera, C; Gutierrez, F; Kindelan, JM; Knobel, H; Leal, M; Lopez-Aldeguer, J; Marino, A; Miralles, C; Molto, J; Ortega, E; Oteo, JA.

Clinical Utility of Maraviroc

CLINICAL DRUG INVESTIGATION. 2011; 31(8): 527-542 Nº de citas: 28 [doi:10.2165/11590700-000000000-00000]

Resino, S; Seoane, JA; Bellon, JM; Dorado, J; Martin-Sanchez, F; Alvarez, E; Cosin, J; Lopez, JC; Lopez, G; Miralles, P; Berenguer, J.

An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients

JOURNAL OF INFECTION. 2011; 62(1): 77-86 Nº de citas: 30 [doi:10.1016/j.jinf.2010.11.003]